Peter Sandercock and IST-3

International Journal of Stroke
  • 0.0 (0)
  • SCIENCE

Acute ischemic stroke is a major public health burden and globally a common cause of death and disability

Episodes

  1. 17/08/2010

    Peter Sandercock and IST-3

    Acute ischemic stroke is a major public health burden and globally a common cause of death and disability. Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischemic stroke within 3 hours of symptom onset. The International Stroke Trial or IST-3 seeks to determine whether a wider range of patients may benefit the International Journal of Stroke spoke to chief investigator Dr Peter Sandercock.

    13 min
  • 1 Episode

About

Acute ischemic stroke is a major public health burden and globally a common cause of death and disability

Information

  • Creator
    International Journal of Stroke
  • Years Active
    2K
  • Episodes
    1
  • Rating
    Clean
  • Copyright
    © http://creativecommons.org/licenses/by/2.0/
  • Show Website
    Peter Sandercock and IST-3